Clinical Trial Update: Post-market Surveillance Study of FLXfit™ TLIF Interbody Fusion Device [NA]

View source ↗

Summary

Post-market surveillance study update for the FLXfit TLIF Interbody Fusion Device by Expanding Orthopedics Ltd.; the current study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Retrolisthesis
• Spondylolisthesis

Drugs mentioned

• FLXfit TLIF Interbody Fusion Device

Snippet

Sponsor: Expanding Orthopedics Ltd. | Conditions: Degenerative Disc Disease, Spondylolisthesis | NA | Status: UNKNOWN